Breast Cancer Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Breast Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: Feb 16, 2019

---

• All breast cancer patients should get genetic testing, surgeons say  
  S Scutti, CNN, February 15, 2019
• Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.  
  Copson Ellen R et al. The Lancet. Oncology 2018 19(2) 169-180
• Influences on decision-making for young women undergoing bilateral prophylactic mastectomy.  
  Glassey Rachael et al. Patient education and counseling 2018 101(2) 318-323
• RAD50 germline mutations are associated with poor survival in BRCA1/2-negative breast cancer patients.  
  Fan Cong et al. International journal of cancer 2018 143(8) 1935-1942
• Unraveling breast cancer risk- Only about 10 percent of people with breast cancer have links to known gene variants, but another 20 percent have significant family history. Scientists are delving deeper into the genome to find what remains unexplained.  
  A Knutsen, Knowable Magazine, February 14, 2019
• Body image problems in women with and without breast cancer 6-20 years after bilateral risk-reducing surgery - A prospective follow-up study.  
  Bai Lucy et al. Breast (Edinburgh, Scotland) 2019 Feb 44120-127
• High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer.  
  Bick Ulrich et al. Breast cancer research and treatment 2019 Feb
• Painting a portrait: Analysis of national health survey data for cancer genetic counseling.  
  Stamp Monica H et al. Cancer medicine 2019 Feb
• Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines.  
  So Min-Kyung et al. Breast cancer (Tokyo, Japan) 2019 Feb
• Personalization of Logical Models With Multi-Omics Data Allows Clinical Stratification of Patients.  
  Béal Jonas et al. Frontiers in physiology 2018 91965